Eli Lilly is trading at $1,148.38, down 3.39%, amid broad risk-off pressure; no clear company-specific catalyst has been identified. - Attacks in Saudi Arabia and tensions around the Strait of Hormuz intensified oil-supply concerns; Reuters reported oil rose more than 5% on October 8. - Rising energy costs and Treasury yields are fueling inflation and interest-rate worries; healthcare is down 1.49% in the supplied sector context.